Patent details

Basic Information

Publication number:

EP2782557

PCT Application Number:

US2012066185

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP128098829

PCT Publication Number:

WO2013078264

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL FORMULATIONS

French Title of Invention:

FORMULATIONS PHARMACEUTIQUES

German Title of Invention:

PHARMAZEUTISCHE FORMULIERUNGEN

SPC Number:

Dates

Filing date:

21/11/2012

Grant date:

12/09/2018

EP Publication Date:

01/10/2014

PCT Publication Date:

30/05/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/09/2018

EP B1 Publication Date:

12/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/11/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/09/2018

 

 

Name:

Array BioPharma Inc.

Address:

3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:

ARONOVA S.A.

From:

16/11/2018

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

SINGH, Rajinder

Address:

United States (US)

2

Name:

LI, Ping

Address:

China (CN)

3

Name:

LEE, Hanchen

Address:

United States (US)

4

Name:

VERMA, Daya

Address:

United States (US)

5

Name:

TAN, LayChoo

Address:

United States (US)

6

Name:

SHEN, Xiaohong

Address:

United States (US)

7

Name:

KRISHNAMACHARI, Yogita

Address:

United States (US)

Priority

Priority Number:

201161563229 P

Priority Date:

23/11/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/28; A61K 9/48; A61K 31/506;

Publication

European Patent Bulletin

1

Issue number:

201837

Publication date:

12/09/2018

Description:

Grant (B1)

2

Issue number:

201838

Publication date:

19/09/2018

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

01/12/2025

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/10/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
16/11/2018	Power Of Attorney	1
06/12/2018	Outgoing Correspondence	1